Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
AFFF Lawsuit Exposure to firefighting foam chemicals may result in an increased risk of cancer for firefighters, military and airport personnel.
Paraquat Parkinson’s Disease Lawsuits Exposure to the toxic herbicide Paraquat has been linked to a risk of Parkinson's disease.
Gardasil HPV Vaccine Lawsuit Side effects of the Gardasil HPV vaccine have been linked to reports of serious and debilitating autoimmune injuries. Lawyers review cases nationwide.
Lawsuits Over DePuy Pinnacle Hip Replacements Moving Forward in MDL April 24, 2012 Austin Kirk Add Your Comments Lawyers involved in the federal litigation over problems with DePuy Pinnacle hip replacements are scheduled to meet with the MDL Court this week, where they are expected to discuss a Case Management Order that will provide a “viable and firm schedule” for proceeding with the lawsuits. A Conference is scheduled to occur on Wednesday morning before U.S. District Judge Ed Kinkeade, who is presiding over the consolidated federal DePuy Pinnacle litigation. In May 2011, the U.S. Judicial Panel on Multidistrict Litigation centralized pretrial proceedings in the cases before Judge Kinkeade in the in the U.S. District Court for the Northern District of Texas, as part of an MDL, or multidistrict litigation. Do You Know About… Childhood Diabetes Lawsuits Against Junk Food Industry Lawyers are now pursuing financial compensation for families of children diagnosed with Type II diabetes, fatty liver disease and other chronic illnesses caused by addictive and harmful substances in ultra-processed foods. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… Childhood Diabetes Lawsuits Against Junk Food Industry Lawyers are now pursuing financial compensation for families of children diagnosed with Type II diabetes, fatty liver disease and other chronic illnesses caused by addictive and harmful substances in ultra-processed foods. Learn More SEE IF YOU QUALIFY FOR COMPENSATION According to a Master Case List issued earlier this month, more than 1,000 DePuy Pinnacle hip lawsuits have already been transferred into the MDL. All of the cases involve similar allegations that design defects with DePuy Pinnacle hip replacements caused plaintiffs to experience problems with their implant within a few years, often resulting in the need for revision surgery. In advance of the conference, Judge Kinkeade asked the parties to meet with a Special Master to discuss their respective views on a Case Management Order, whether separate tracks should be created for different configurations of the DePuy Pinnacle hip, and other procedural issues, including coordination with lawsuits pending in state court. The parties were also asked to reach an agreement for a long-form and short-form complaint procedure, a fact sheet that will be completed by each plaintiff to provide additional information on the background of their claim, and a protocol for joint production of documents and designation of privileged documents. In addition to defending the lawsuits over DePuy Pinnacle hip replacements, Johnson & Johnson and DePuy also face thousands of lawsuits over their DePuy ASR hip replacement, which was pulled from the market in August 2010 due to a higher-than-expected failure rate. Those cases are consolidated in a separate MDL, which is pending in the U.S. District Court for the Northern District of Ohio. The DePuy ASR hip was approved as a substantial equivalent design to the DePuy Pinnacle metal-on-metal hip. According to allegations raised in several complaints, a DePuy Pinnacle hip recall should have also be issued due to similar design problems. Tags: DePuy Hip Replacement, DePuy Pinnacle, DePuy Pinnacle Hip, DePuy Pinnacle Metal-on-Metal Hip Replacement, Hip Replacement, Johnson & Johnson More Lawsuit Stories Hair Relaxer Wrongful Death Lawsuit Links Fatal Endometrial Cancer to Chemical Straightener Use March 4, 2025 Deadlines Leading to First Valsartan Bellwether Trial on Sept. 8, 2025 Outlined by Special Master March 4, 2025 Olympus Endoscope Guide Sheath Recall Issued After Multiple Injuries Following Tip Detachment March 4, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermPhoneThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Hair Relaxer Wrongful Death Lawsuit Links Fatal Endometrial Cancer to Chemical Straightener Use (Posted: today) A hair relaxer wrongful death lawsuit blames 16 years of using popular hair relaxer products like Just for Me and Dark & Lovely for the development of a fatal case of endometrial cancer. MORE ABOUT: HAIR RELAXER LAWSUITHair Relaxer Lawsuit Settlement Talks Begin With Focus on Finding Mediator, Parties Report (02/11/2025)Judge Indicates 40 Hair Relaxer Lawsuits Over Uterine Cancer, Endometrial Cancer and Ovarian Cancer Will Be Selected for Early Trial Program (02/03/2025)FDA Hair Relaxer Formaldehyde Ban Uncertain After All Pending Regulations Frozen: NBC Reports (01/24/2025) Depo-Provera Injury Lawyers To Apply for Leadership Positions in MDL (Posted: yesterday) Judge is calling for Depo-Provera lawyers to submit applications for MDL leadership by the end of the week, indicating that female attorneys should be adequately represented. MORE ABOUT: DEPO-PROVERA LAWSUITJudge Selects Five Depo-Provera Brain Tumor Lawsuits for “Pilot” Trials Weeks After MDL Established (02/25/2025)Depo-Provera Lawyers Will Meet With MDL Judge For Initial Case Management Conference on Friday (02/18/2025)Side Effects of Combined Hormonal Contraceptives Carry Higher Blood Clot Risks Than Others: Study (02/18/2025) Oxbryta Injury Lawsuit Over Discontinued Sickle Cell Disease Drug Set for Trial in June 2027 (Posted: 4 days ago) A federal judge has scheduled an Oxbryta lawsuit to go before a jury on June 7, 2027, which may be the first trial over side effects of the discontinued sickle cell disease drug. MORE ABOUT: OXBRYTA LAWSUITOxbryta Class Action Lawsuit Filed by Former Users of Sickle Cell Disease Drug Recalled in 2024 (12/30/2024)Lawsuit Alleges Oxbryta Side Effects Resulted in Higher Rate of Vaso-Occlusive Crisis, Other Debilitating Symptoms (11/19/2024)Oxbryta Recall Lawsuits Claim Drug Manufacturer Knew About Fatality Risks for Years (11/08/2024)
Hair Relaxer Wrongful Death Lawsuit Links Fatal Endometrial Cancer to Chemical Straightener Use March 4, 2025
Deadlines Leading to First Valsartan Bellwether Trial on Sept. 8, 2025 Outlined by Special Master March 4, 2025
Olympus Endoscope Guide Sheath Recall Issued After Multiple Injuries Following Tip Detachment March 4, 2025
Hair Relaxer Wrongful Death Lawsuit Links Fatal Endometrial Cancer to Chemical Straightener Use (Posted: today) A hair relaxer wrongful death lawsuit blames 16 years of using popular hair relaxer products like Just for Me and Dark & Lovely for the development of a fatal case of endometrial cancer. MORE ABOUT: HAIR RELAXER LAWSUITHair Relaxer Lawsuit Settlement Talks Begin With Focus on Finding Mediator, Parties Report (02/11/2025)Judge Indicates 40 Hair Relaxer Lawsuits Over Uterine Cancer, Endometrial Cancer and Ovarian Cancer Will Be Selected for Early Trial Program (02/03/2025)FDA Hair Relaxer Formaldehyde Ban Uncertain After All Pending Regulations Frozen: NBC Reports (01/24/2025)
Depo-Provera Injury Lawyers To Apply for Leadership Positions in MDL (Posted: yesterday) Judge is calling for Depo-Provera lawyers to submit applications for MDL leadership by the end of the week, indicating that female attorneys should be adequately represented. MORE ABOUT: DEPO-PROVERA LAWSUITJudge Selects Five Depo-Provera Brain Tumor Lawsuits for “Pilot” Trials Weeks After MDL Established (02/25/2025)Depo-Provera Lawyers Will Meet With MDL Judge For Initial Case Management Conference on Friday (02/18/2025)Side Effects of Combined Hormonal Contraceptives Carry Higher Blood Clot Risks Than Others: Study (02/18/2025)
Oxbryta Injury Lawsuit Over Discontinued Sickle Cell Disease Drug Set for Trial in June 2027 (Posted: 4 days ago) A federal judge has scheduled an Oxbryta lawsuit to go before a jury on June 7, 2027, which may be the first trial over side effects of the discontinued sickle cell disease drug. MORE ABOUT: OXBRYTA LAWSUITOxbryta Class Action Lawsuit Filed by Former Users of Sickle Cell Disease Drug Recalled in 2024 (12/30/2024)Lawsuit Alleges Oxbryta Side Effects Resulted in Higher Rate of Vaso-Occlusive Crisis, Other Debilitating Symptoms (11/19/2024)Oxbryta Recall Lawsuits Claim Drug Manufacturer Knew About Fatality Risks for Years (11/08/2024)